Terapie a base di cellule staminali e neuropatologie: qual è la verità?

In questo periodo, diverse dichiarazioni hanno suggerito che le cellule staminali possano già essere impiegate oggi nel trattamento di persone affette da neuropatologie. Ma cosa si sa veramente di queste terapie e come interpretare queste dichiarazioni?


Stem cell therapies and neurological disorders of the brain: what is the truth?

There have been several claims that stem cells can already be used in patients affected by neurological disorders. What do we really know about these therapies and how should these claims be viewed?

Eight tiny organs grown by scientists

On 20 July researchers at the MRC Centre for Regenerative Medicine announced that they had regrown damaged livers in mice. It’s just one example of scientists growing tiny versions of organs in animals and in the lab to study development and disease, and test potential treatments. Many of these organs also represent the first steps towards growing whole organs – or parts of organs – for transplant. MRC Science Writer Cara Steger rounds up progress.

Regulation of unproven stem cell therapies – medicinal product or medical procedure?

This article is the second in a series of posts about unproven stem cell treatments by guest authors Casimir MacGregor, Alan Petersen and Megan Munsie. Their first post took a closer look at Germany's X-Cell Center and stem cell tourism. Here they consider the regulatory frameworks governing unproven stem cell treatments in Europe, the US and Australia.

Stem cell research: promise, progress and hype

The melting pot of expectations, hope, responsibility, idealism and realism in the field of stem cell research were the subject of a panel discussion for media representatives at the recent ISSCR Conference in Stockholm titled “Stem cell research: promise, progress and hype".

Organoids for personalized cancer treatment

Two studies published in Nature and Cell this month show that organoids, miniature organs that can be cultured in a dish, could be crucial for personalized treatment of cancer.

GSCN video: Andreas Trumpp (EN)

In this short video by the German Stem Cell Network, scientist Andreas Trumpp talks about his research on cancer stem cells.

In German, dubbed into English.

GSCN video: Magdalena Götz (EN)

Magdalena Götz from the Helmholtz Zentrum München is a leading researcher in the field of neuronal stem cells.

In this video, produced by the German Stem Cell Network, she talks about her work. In German, dubbed into English.


project logo

Repair-HD researchers are taking on the complex task of exploring cell replacement therapy in HD over the next four years. Funded under the Seventh Framework Programme (FP7), the project aims to enable efficient translation of experimental stem cell therapies to preclinical work in small and large animal models, and readiness for clinical application.

Related content: 

Neue Hilfsmittel zur Erforschung von Krankheiten: Umprogrammierte Zellen zur Modellierung von Krankheiten

Last updated:
15 Jul 2013

Um Erkrankungen zu verstehen und erfolgreich zu bekämpfen muss Forschung betrieben werden. Jedoch wird diese oft durch eingeschränkten Zugang zu Patienten oder dem fehlenden Vorhandensein von erkranktem Gewebe, erschwert oder unmöglich gemacht. 'Krankheitsmodelle' können diese Probleme umgehen indem sie Wissenschaftlern ermöglicht Krankheiten im Labor zu überwachen. Stammzellen, besonders sogenannte induzierte pluripotente Stammzellen (iPS Zellen), ermöglichen es Wissenschaftlern Krankheiten, für die es bisher kaum Studienmaterial gab, im Labor zu modellieren und daraus neue Erkenntnisse zu gewninnen. 

Syndicate content